Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.

Future oncology (London, England) - 1 Sept 2016

Pinto Carmine, Bella Maria Angela, Capoluongo Ettore, Carrera Paola, Clemente Claudio, Colombo Nicoletta, Cortesi Laura, De Rosa Gaetano, Fenizia Francesca, Genuardi Maurizio, Gori Stefania, Guarneri Valentina, Marchetti Antonio, Marchetti Paolo, Normanno Nicola, Pasini Barbara, Pignata Sandro, Radice Paolo, Ricevuto Enrico, Russo Antonio, Tagliaferri Pierosandro, Tassone Pierfrancesco, Truini Mauro, Varesco Liliana

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Informed Consent

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 27241581
DOI: 10.2217/fon-2016-0189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.PMID 27241581Read ↗

Hereditary breast-ovarian cancer: clinical findings and medical management.Semantic proximity Read ↗

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionSemantic proximity Read ↗

NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian CancerSemantic proximity Read ↗

The sooner the better: Genetic testing following ovarian cancer diagnosisSemantic proximity Read ↗

Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

ACOG committee opinion. Breast-ovarian cancer screening. Number 239, August 2000. American College of Obstetricians and Gynecologists. Committee on genetics.Semantic proximity Read ↗

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.Semantic proximity Read ↗

The clinical implications of genetics. BRCA1- and BRCA2-positive: how do I proceed? Implications for ovarian cancer prevention.Semantic proximity Read ↗

Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.Semantic proximity Read ↗

AGO Austria recommendations for genetic testing of patients with ovarian cancer.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.